what does alembic pharmaceuticals do

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished drug formulations, with a focus on generics and compliance through its R&D and manufacturing facilities.

what products does alembic pharmaceuticals make

The company produces high-quality generic medicines, APIs through fermentation and chemistry-based methods, and operates as a trusted supplier of affordable pharmaceuticals across India and globally.

what sector is alembic pharmaceuticals in

Alembic Pharmaceuticals is part of the pharmaceutical sector, specifically involved in the research, development, manufacturing, and marketing of APIs and formulations.

when was alembic pharmaceuticals founded

Founded in 1932, Alembic Pharmaceuticals has a long-standing history in the Indian pharmaceutical industry, evolving from a small firm to a multinational company with a strong presence in Gujarat.

who owns alembic pharmaceuticals

Alembic Pharmaceuticals is a publicly listed company on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE), owned by its shareholders, with significant operations and market presence in India and beyond.

APLLTD

NSEBSE

Alembic Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE901L01018· Scrip: 533573

EN हिन्दी ગુજરાતી मराठी

₹૭૮૩.૭૦

▼ 1.80 (-0.23%)

7/5/2026, 11:53:20 am

NSE

₹૭૮૩.૭૦

▼ ૧.૮૦

-૦.૨૩%

BSE

₹૭૮૫.૬૫

▲ ૧૬.૯૫

+૦.૦૦%

૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો

આજ 

ખૂલ્લ૭૯૫.૦૦

ઊંચ૭૯૫.૦૦

નીચ૭૮૧.૨૦

અગાઉ બંધ૭૮૫.૫૦

વૉલ્યુમ૨૫,૨૬૮

મૂલ્ય₹૨.૦Cr

L: 781.20H: 795.00

52 સપ્તાહ

નીચ₹૬૩૫.૮૦

ઊંચ₹૧,૧૦૭.૯૦

૩૧% 52 સપ્તાહ રેન્જમાં

માહિતી

અંકિત મૂલ્ય₹૨

સૂચિબદ્ધ2011-09-20

ISININE901L01018

SeriesA

BSE સ્ક્રિપ533573

મુખ્ય સૂચકો

1D

+1.87%

1W

+3.20%

1M

+15.75%

3M

+2.50%

6M

-14.96%

મૂલ્યાંકન

P/E (TTM)૨૫.૫૧

P/E (Qtr Ann.)૨૭.૯૫

P/Sales૨.૦૭

બજાર મૂડી₹13277 Cr

વૃદ્ધિ (ત્રિ.)

આવક+2.72%

PAT-10.09%

EPS-10.01%

નફાકારકતા

EBITDA માર્જિન૧૪.૬%

ચોખ્ખો માર્જિન૮.૧%

TTM EBITDA M.૧૫.૨%

TTM ચોખ્ખો M.૯.૪%

ડિવિડન્ડ

યીલ્ડ૧.૪૦%

છેલ્લો DPS₹૧૧

ચૂકવણી ગુણોત્તર૧૫૬.૯%

વૃદ્ધિ+0.00%

TTM આવક

₹6419 Cr

TTM EBITDA

₹976 Cr

TTM PAT

₹604 Cr

TTM EPS

₹૩૦.૭૨

પ્રતિ શેર આવક

₹૩૨૬.૬

ત્રિમાસિક નાણાકીય

આવક

EBITDA

PAT

EPS

ત્રિમાસ	આવક	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	1693 Cr	1525 Cr	247 Cr	177 Cr	138 Cr	₹7.01
2024-09-30	1648 Cr	1498 Cr	250 Cr	180 Cr	153 Cr	₹7.79
2024-06-30	1562 Cr	1407 Cr	226 Cr	157 Cr	135 Cr	₹6.85
2024-03-31	1517 Cr	1337 Cr	253 Cr	183 Cr	178 Cr	₹9.07
2023-12-31	1631 Cr	1449 Cr	254 Cr	185 Cr	180 Cr	₹9.18
2023-09-30	1595 Cr	1470 Cr	203 Cr	135 Cr	137 Cr	₹6.95
2023-03-31	1406 Cr	1283 Cr	199 Cr	125 Cr	153 Cr	₹7.76
2022-12-31	1509 Cr	1341 Cr	235 Cr	168 Cr	122 Cr	₹6.20

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન — 2026-03-31

પ્રમોટર69.7%

FII4.3%

DII16.2%

સાર્વજનિક30.3%

પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખ	પ્રકાર	હેતુ
2025-07-29	Dividend	Dividend - Rs 11 Per Share
2024-07-15	Dividend	Dividend - Rs 11 Per Share
2023-07-28	Dividend	Dividend - Rs 8 Per Share
2022-08-17	Dividend	Interim Dividend - Rs 10 Per Share
2021-07-19	Dividend	Annual General Meeting/Dividend - Rs 14 Per Share
2020-03-16	Dividend	Interim Dividend - Rs 7 Per Share Special Dividend - Rs 3 Per Share
2019-07-18	Dividend	Annual General Meeting/Dividend Rs 5.50/-
2018-07-18	Dividend	Annual General Meeting/Dividend- Rs 4 Per Share (Purpose Revised)
2017-07-11	Dividend	Annual General Meeting/Dividend -Rs 4/- Per Share
2016-07-20	Dividend	Annual General Meeting/Dividend - Rs 4/- Per Share
2015-07-22	Dividend	Annual General Meeting/ Dividend - Rs 3.50/- Per Share
2014-07-17	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2013-07-29	Dividend	Annual General Meeting And Dividend Rs.2.50 Per Share
2012-07-31	Dividend	Annual General Meeting / Dividend Rs 1.40 Per Share

કમાણી ટ્રાન્સક્રિપ્ટ

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

4 Nov 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

5 Aug 2025NSE15K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

6 May 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

3 Feb 2025NSE17K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

7 Nov 2023NSE16K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

4 Aug 2023NSE12K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation

5 May 2023NSE14K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...

26 Apr 2023NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

17 Nov 2022NSE32K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional I...

9 Nov 2022NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

10 Aug 2022NSE33K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Revision in timings of Post Results ...

2 Aug 2022NSE3K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional...

9 May 2022NSE45K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor ...

9 Jan 2019NSE2K chars

Read →

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 21...

21 Jan 2016NSE

Read →

Alembic Pharmaceuticals Limited has informed the Exchange that the Company will hold Post Results Co...

19 Jan 2016NSE

Read →

ભાવ ઇતિહાસ

તારીખ	ખૂલ્લ	ઊંચ	નીચ	બંધ	વૉલ્યુમ
2026-05-06	૭૭૩.૯૫	૭૯૩.૨૦	૭૬૪.૭૫	૭૮૫.૫૦	૪.૧૪L
2026-05-05	૭૬૭.૦૦	૭૭૫.૦૦	૭૬૨.૯૦	૭૬૯.૩૦	૨.૪૨L
2026-05-04	૭૫૯.૯૫	૭૭૦.૯૫	૭૫૫.૦૦	૭૬૫.૭૫	૩.૩૮L
2026-04-30	૭૬૦.૦૦	૭૬૨.૦૦	૭૫૧.૩૫	૭૫૫.૦૦	૨૭,૩૧૪
2026-04-29	૭૫૯.૯૫	૭૬૯.૦૦	૭૫૩.૬૦	૭૬૧.૧૦	૫૨,૪૯૮
2026-04-28	૭૬૨.૫૫	૭૬૭.૭૦	૭૫૩.૧૫	૭૫૯.૪૦	૩૪,૯૧૫
2026-04-27	૭૮૪.૮૫	૭૯૫.૯૫	૭૬૦.૧૦	૭૬૪.૬૦	૧.૬૭L
2026-04-24	૭૮૧.૨૫	૭૮૧.૨૫	૭૫૦.૦૦	૭૫૧.૦૫	૪૦,૭૨૪
2026-04-23	૭૬૪.૦૦	૭૮૪.૬૦	૭૬૧.૭૫	૭૬૮.૭૫	૬૭,૫૯૮
2026-04-22	૭૬૦.૮૫	૭૭૩.૧૫	૭૫૮.૨૫	૭૬૪.૬૦	૩૦,૨૯૦
2026-04-21	૭૫૭.૫૦	૭૬૭.૮૦	૭૫૦.૨૦	૭૬૪.૩૦	૬૨,૯૧૭
2026-04-20	૭૮૪.૮૫	૭૮૫.૦૦	૭૫૫.૦૦	૭૫૭.૫૦	૭૦,૭૫૭
2026-04-17	૭૫૩.૯૫	૭૯૭.૦૦	૭૫૧.૩૫	૭૮૪.૭૫	૨.૩૮L
2026-04-16	૭૪૬.૦૦	૭૫૩.૬૫	૭૩૩.૨૫	૭૪૮.૩૦	૮૫,૮૬૦
2026-04-15	૭૨૮.૯૫	૭૪૧.૫૦	૭૨૦.૧૦	૭૩૪.૮૦	૮૨,૬૬૦
2026-04-13	૭૧૫.૦૦	૭૨૮.૨૦	૭૦૪.૫૦	૭૧૭.૫૦	૪૪,૮૬૫
2026-04-10	૭૨૦.૨૫	૭૩૬.૧૫	૭૨૦.૨૫	૭૨૪.૨૦	૩૫,૫૮૩
2026-04-09	૭૨૫.૯૫	૭૨૯.૬૫	૭૧૫.૮૫	૭૨૦.૧૫	૪૧,૫૨૪
2026-04-08	૭૧૬.૦૦	૭૪૮.૦૦	૭૦૦.૦૦	૭૨૬.૨૫	૧.૫૮L
2026-04-07	૬૫૫.૫૫	૬૯૫.૦૦	૬૫૨.૧૫	૬૯૦.૧૦	૧.૩૫L
2026-04-02	૬૬૬.૫૦	૬૭૩.૫૫	૬૫૦.૦૦	૬૫૬.૨૦	૬૦,૯૨૨
2026-04-01	૬૬૮.૯૫	૬૮૧.૪૫	૬૬૫.૨૫	૬૭૭.૦૫	૫૮,૧૬૨
2026-03-27	૬૯૪.૦૦	૬૯૪.૧૫	૬૬૬.૦૦	૬૭૩.૫૫	૭.૧૦L
2026-03-25	૬૭૫.૦૦	૬૯૯.૦૦	૬૬૭.૨૦	૬૯૪.૧૫	૨.૭૧L
2026-03-24	૬૬૨.૦૦	૬૭૮.૫૫	૬૩૮.૧૫	૬૭૩.૨૦	૧.૭૪L
2026-03-20	૬૫૬.૯૫	૬૮૬.૯૫	૬૫૬.૯૫	૬૭૭.૩૦	૭૦,૩૮૬
2026-03-19	૬૭૦.૦૦	૬૭૧.૩૫	૬૫૨.૦૦	૬૫૫.૪૫	૪૭,૯૩૦
2026-03-18	૬૭૨.૯૦	૬૮૪.૦૦	૬૬૯.૪૦	૬૭૬.૩૦	૪૭,૯૧૪
2026-03-17	૬૭૫.૭૫	૬૮૨.૪૫	૬૬૫.૧૦	૬૭૦.૦૦	૩૫,૦૫૩
2026-03-16	૬૭૮.૦૦	૬૮૬.૯૦	૬૬૭.૦૫	૬૭૫.૩૦	૫૨,૩૧૫

વારંવાર પૂછાતા પ્રશ્નો

વિશે

એલેમ્બિક ફાર્માસ્યુટિકલ્સ લિમિટેડ, ભારતના ફાર્માસ્યુટિકલ ક્ષેત્રની અગ્રણી ખેલાડી, મુખ્યત્વે જેનરિક અને સ્પેશિયાલિટી ફાર્માસ્યુટિકલ ઉત્પાદનોના વિકાસ, ઉત્પાદન અને માર્કેટિંગ પર ધ્યાન કેન્દ્રિત કરે છે. એટોર્વાસ્ટેટિન કેલ્શિયમ અને મેટફોર્મિન હાઇડ્રોક્લોરાઇડ જેવા મુખ્ય ફોર્મ્યુલેશન સહિત તેની પરવડે તેવી દવાઓની વિશાળ શ્રેણી માટે જાણીતી, કંપનીએ 1950 માં તેની શરૂઆતથી ભારતીય જેનરિક ઉદ્યોગમાં નોંધપાત્ર યોગદાન આપનાર તરીકે પોતાને સ્થાપિત કરી છે.